Advertisement
Screener

Johnson & Johnson (JNJ) ROA

JOHNSON & JOHNSON ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • JOHNSON & JOHNSON roa for the quarter ending 2026-06-28 was 10.46%, a 10.71% decline year-over-year.
  • JOHNSON & JOHNSON roa for the quarter ending 2026-03-29 was 10.47%, a 7.00% decline year-over-year.
  • JOHNSON & JOHNSON roa for the quarter ending 2025-12-28 was 13.46%, a 72.28% increase year-over-year.
  • JOHNSON & JOHNSON roa for the quarter ending 2025-09-28 was 13.03%, a 58.17% increase year-over-year.
  • JOHNSON & JOHNSON roa for fiscal 2025 was 13.46%, a 72.28% increase from fiscal 2024.
  • JOHNSON & JOHNSON roa for fiscal 2024 was 7.81%, a 62.77% decline from fiscal 2023.
  • JOHNSON & JOHNSON roa for fiscal 2023 was 20.98%, a 119.11% increase from fiscal 2023.
  • JOHNSON & JOHNSON roa for fiscal 2023 was 9.57%, a 16.53% decline from fiscal 2022.
Available history
2011-01-02 to 2026-06-28
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-2810.46%$21.04B$5.53B$201.06B
2026-03-2910.47%$21.04B$5.24B$200.89B
2025-12-2813.46%$26.8B$5.12B$199.21B
2025-09-2813.03%$25.12B$5.15B$192.82B
2025-06-2911.72%$22.66B$5.54B$193.39B
2025-03-3011.26%$21.81B$11.00B$193.67B
2024-12-297.81%$14.07B$3.43B$180.1B
2024-09-298.24%$14.68B$2.69B$178.29B
2024-06-3020.99%$38.02B$4.69B$181.09B
2024-03-3122.37%$38.48B$3.25B$171.97B
2023-12-3120.98%$35.15B$4.05B$167.56B
2023-10-0120.85%$34.62B$26.03B$166.06B
2023-07-026.81%$13.05B$5.14B$191.69B
2023-04-026.49%$12.72B-$68.00M$195.97B
2023-01-019.57%$17.94B$3.52B$187.38B
2022-10-0210.94%$19.16B$4.46B$175.12B
2022-07-0310.33%$18.37B$4.81B$177.72B
2022-04-0311.12%$19.83B$5.15B$178.36B
2022-01-0211.47%$20.88B$4.74B$182.02B
2021-10-039.98%$17.88B$3.67B$179.23B
2021-07-0410.07%$17.77B$6.28B$176.44B
2021-04-048.76%$15.12B$6.20B$172.56B
2021-01-038.41%$14.71B$1.74B$174.89B
2020-09-279.95%$16.99B$3.55B$170.69B
2020-06-289.59%$15.19B$3.63B$158.38B
2020-03-2911.07%$17.17B$5.80B$155.02B
2019-12-299.59%$15.12B$4.01B$157.73B
2019-09-299.10%$14.15B$1.75B$155.52B
2019-06-3010.53%$16.33B$5.61B$155.12B
2019-03-319.78%$14.68B$3.75B$150.03B
2018-12-3010.00%$15.3B$3.04B$152.95B
2018-09-300.99%$1.54B$3.93B$155.7B
2018-07-010.88%$1.37B$3.95B$155.37B
2018-04-010.79%$1.25B$4.37B$156.63B
2017-12-310.83%$1.3B-$10.71B$157.3B
2017-10-0110.17%$15.83B$3.76B$155.66B
2017-07-0210.69%$16.34B$3.83B$152.81B
2017-04-0211.39%$16.51B$4.42B$144.92B
2017-01-0111.71%$16.54B$3.81B$141.21B
2016-10-0211.36%$15.94B$4.27B$140.37B
2016-07-0310.75%$15.03B$4.00B$139.81B
2016-04-0311.41%$15.55B$4.46B$136.23B
2016-01-0311.55%$15.41B$3.21B$133.41B
2015-09-2711.04%$14.72B$3.36B$133.27B
2015-06-2812.20%$16.11B$4.52B$132.04B
2015-03-2912.38%$15.92B$4.32B$128.59B
2014-12-2812.52%$16.32B$2.52B$130.36B
2014-09-2813.11%$17.32B$4.75B$132.1B
2014-06-2911.50%$15.55B$4.33B$135.2B
2014-03-3011.30%$15.06B$4.73B$133.33B
2013-12-2910.42%$13.83B$3.52B$132.68B
2013-09-2910.15%$12.88B$2.98B$126.93B
2013-06-3010.35%$12.87B$3.83B$124.33B
2013-03-318.59%$10.44B$3.50B$121.54B
2012-12-308.94%$10.85B$2.57B$121.35B
2012-09-307.15%$8.5B$2.97B$118.95B
2012-07-017.55%$8.74B$1.41B$115.75B

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-2813.46%$26.8B$199.21B
2024-12-297.81%$14.07B$180.1B
2023-12-3120.98%$35.15B$167.56B
2023-01-019.57%$17.94B$187.38B
2022-01-0211.47%$20.88B$182.02B
2021-01-038.41%$14.71B$174.89B
2019-12-299.59%$15.12B$157.73B
2018-12-3010.00%$15.3B$152.95B
2017-12-310.83%$1.3B$157.3B
2017-01-0111.71%$16.54B$141.21B
2016-01-0311.55%$15.41B$133.41B
2014-12-2812.52%$16.32B$130.36B
2013-12-2910.42%$13.83B$132.68B
2012-12-308.94%$10.85B$121.35B
2012-01-018.51%$9.67B$113.64B
2011-01-0212.96%$13.33B$102.91B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38